Bain Capital
http://www.baincapital.comBain Capital, LLC is a global private investment firm that manages several pools of capital including private equity, venture capital, public equity and leveraged debt assets with more than $65 billion in assets under management. Since its inception in 1984, Bain Capital has made private equity investments and add-on acquisitions in more than 300 companies in a variety of industries around the world, and has a team of almost 300 professionals dedicated to investing in and supporting its portfolio companies, including such leading companies as Dunkin' Donuts, Michaels Stores and Domino's Pizza. Headquartered in Boston, Bain Capital has offices in New York, London, Munich, Hong Kong, Shanghai and Tokyo.
View Older Stories View More Recent Stories
-
The RMR Group Appoints Peter Welch as Senior Vice President to Lead International Capital Formation
-
Form D Bain Capital Insurance
-
New Study Finds Nearly 7,900 Traffic Violations In 30-Minute Windows
-
Rocket Software and K2view Partner to Accelerate Mainframe Modernization with Governed, AI-Ready Test Data for Testing, Analytics, and AI
-
Titan Aviation Leasing Acquires Boeing 777-300ER to Support China Airlines’ Long-Haul Growth
-
Form D/A Bain Capital Global Dire
-
Dealmakers see more retail mergers and IPOs in 2026 after tariffs sidelined M&A last year
-
Strive completes Semler Scientific acquisition, holds 12,798 bitcoin
-
Strive Announces the Completion of Semler Scientific Acquisition
-
Altai Capital nominates two candidates to OraSure board
-
Altai Capital Management Nominates Two Highly-Qualified Candidates for Election to OraSure Board of Directors
-
DentalXChange Announces New Chief Solutions Officer
-
Bain & Company formalizes partnership with seven flagship venture capital firms to drive AI innovation opportunities for clients
-
Coca‑Cola scraps Costa Coffee sale, FT reports
-
Bain Capital Real Estate Closes on $5 Billion in New Capital, Expanding Scale Across High-Conviction Strategies
-
Defense Unicorns valued at $1 billion in latest funding round
-
DEFENSE UNICORNS RAISES $136 MILLION SERIES B TO BUILD THE SOFTWARE BACKBONE OF THE DEPARTMENT OF WAR
-
Cardamom® announces investment by Valspring Capital to support rapid growth
-
Form 424B3 Lincoln Bain Capital
-
Bob's Discount Furniture reveals revenue and profit growth in US IPO filing
-
Bain Capital and BlueWater Marinas Acquire Kent Narrows Boatel
-
Exclusive-Bain's Manappuram deal delayed by Indian regulatory concerns, sources say
-
Form SCHEDULE 13G/A Bain Capital Private Filed by: Bain Capital Asset Management, LP
-
Form SCHEDULE 13D/A Mersana Therapeutics, Filed by: Bain Capital Life Sciences Fund II, L.P.
-
American College of Education Receives Strategic Growth Investment from Bain Capital Double Impact
-
Alkeus Pharmaceuticals to Present Corporate Update at the 44th Annual J.P. Morgan Healthcare Conference
-
Tenax Aerospace Completes Refinancing and Junior Capital Buyout
-
Form D Bain Capital Real Estate
-
Norm Ai Launches AI-Driven DDQ and RFP Completion Solution to Transform Institutional Questionnaire Workflows
-
Dent Wizard Announces Bryan Wynn as CEO
-
Dominus Capital Announces Sale of Surface Preparation Technologies
-
Kasowitz Secures Court Sanctions Against Envestnet, Inc., a Financial Services Company Owned by Bain Capital, for Intentional Destruction of Evidence
-
Bain Capital buying South Korean activewear firm Echo Marketing in $344 million deal
-
Form D Bain Capital Global Dire
-
Form 8-K Bain Capital Private For: Dec 29
-
BRP completes secondary offering as Bain Capital sells 1.85 million shares
-
BRP and its Principal Shareholder Announce Closing of Previously Announced Secondary Offering
-
Form 3 Bain Capital GSS Investm For: Dec 18 Filed by: Purves Michael Ewing
-
Form 8-K Bain Capital Specialty For: Dec 22
-
Form 4 Bain Capital GSS Investm For: Dec 18 Filed by: Bain Capital GSS Investment Sponsor LLC
-
Bain Capital Specialty Finance (BCSF) Declares $0.15 Special Dividend; 1.1% Yield
-
Bain Capital Specialty Finance, Inc. Announces Special Dividend of $0.15 per Share
-
Tanabe Pharma America Announces Transfer of RADICAVA® Business to Shionogi
-
Shionogi Expands Rare Disease Presence with Planned Acquisition of Global Rights to Tanabe Pharma Corporation’s RADICAVA ORS® (edaravone) and IV RADICAVA
-
Form 8-K Bain Capital GSS Investm For: Dec 18
-
ADFW 2025 Delivers Successful Edition, Showcasing Abu Dhabi's Next Decade of Growth with Over 35,000 Attendees
-
Exclusive-Starbucks supplier Cuisine Solutions hires Morgan Stanley and Rothschild for potential sale, sources say
-
Syremis Therapeutics Launches with $165M to Develop Best-in-Class Medicines for Mental Health Conditions
-
Analysis-More mega deals coming as chase for scale fuels near record-breaking year for M&A
-
Bain Capital Launches AI Quant Intelligence Program with NVIDIA Technical Support
